• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化基金会患者登记处。一个国家观察性疾病登记处的设计与方法。

The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.

作者信息

Knapp Emily A, Fink Aliza K, Goss Christopher H, Sewall Ase, Ostrenga Josh, Dowd Christopher, Elbert Alexander, Petren Kristofer M, Marshall Bruce C

机构信息

1 Cystic Fibrosis Foundation, Bethesda, Maryland.

2 Department of Medicine, University of Washington, Seattle, Washington; and.

出版信息

Ann Am Thorac Soc. 2016 Jul;13(7):1173-9. doi: 10.1513/AnnalsATS.201511-781OC.

DOI:10.1513/AnnalsATS.201511-781OC
PMID:27078236
Abstract

RATIONALE

The Cystic Fibrosis Foundation Patient Registry (CFFPR) is an ongoing patient registry study that collects longitudinal demographic, clinical, and treatment information about persons with cystic fibrosis (CF) in the United States. CF is a life-shortening genetic disorder that occurs in approximately 1 in 3,500 births in the United States. High-quality observational data is important for clinical research, quality improvement, and clinical management.

OBJECTIVES

To describe the data collection, patient population, and key limitations of the CFFPR.

METHODS

Inclusion criteria for the CFFPR include diagnosis with CF or a CFTR-associated disorder, care at an accredited care center program, and provision of informed consent. Data from clinic visits and hospitalizations are collected through a secure website. Loss to follow-up and generalizability were examined using several methods. The accuracy of CFFPR data was evaluated with an audit of 2012 CFFPR data compared to the medical record.

MEASUREMENTS AND MAIN RESULTS

Since 1986, the CFFPR contains the records of 48,463 individuals with CF. Participation among individuals seen at accredited care centers is high, and loss to follow-up is low. An audit of 2012 CFFPR data suggests that the CFFPR contains 95% of clinic visits and 90% of hospitalizations found in the medical record for these patients, and nearly all of the audited fields were highly accurate.

CONCLUSIONS

Registries such as the CFFPR are important tools for research, clinical care, and tracking incidence, mortality and population trends.

摘要

理论依据

囊性纤维化基金会患者注册库(CFFPR)是一项正在进行的患者注册库研究,收集美国囊性纤维化(CF)患者的纵向人口统计学、临床和治疗信息。CF是一种缩短寿命的遗传性疾病,在美国约每3500例出生中就有1例发生。高质量的观察性数据对于临床研究、质量改进和临床管理至关重要。

目的

描述CFFPR的数据收集、患者群体及主要局限性。

方法

CFFPR的纳入标准包括诊断为CF或CFTR相关疾病、在经认可的护理中心项目接受护理以及提供知情同意书。门诊和住院数据通过安全网站收集。采用多种方法检查失访情况和可推广性。通过将2012年CFFPR数据与病历进行比对审核来评估CFFPR数据的准确性。

测量指标和主要结果

自1986年以来,CFFPR包含了48463名CF患者的记录。在经认可的护理中心就诊的患者参与度高,失访率低。对2012年CFFPR数据的审核表明,CFFPR包含了这些患者病历中95%的门诊就诊记录和90%的住院记录,且几乎所有审核字段都高度准确。

结论

像CFFPR这样的注册库是研究、临床护理以及追踪发病率、死亡率和人群趋势的重要工具。

相似文献

1
The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.囊性纤维化基金会患者登记处。一个国家观察性疾病登记处的设计与方法。
Ann Am Thorac Soc. 2016 Jul;13(7):1173-9. doi: 10.1513/AnnalsATS.201511-781OC.
2
Cystic fibrosis prevalence in the United States and participation in the Cystic Fibrosis Foundation Patient Registry in 2020.2020 年美国囊性纤维化的患病率和参与囊性纤维化基金会患者登记处的情况。
J Cyst Fibros. 2023 May;22(3):436-442. doi: 10.1016/j.jcf.2023.02.009. Epub 2023 Mar 13.
3
Linkage of the CF foundation patient registry with the pediatric health information system database.CF 基金会患者登记处与儿科健康信息系统数据库的链接。
Pediatr Pulmonol. 2019 Jun;54(6):721-728. doi: 10.1002/ppul.24272. Epub 2019 Mar 18.
4
Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry.2000年至2010年及以后囊性纤维化患者的寿命:囊性纤维化基金会患者登记处的生存分析
Ann Intern Med. 2014 Aug 19;161(4):233-41. doi: 10.7326/M13-0636.
5
Gaps in Cystic Fibrosis Care Are Associated with Reduced Lung Function in the U.S. Cystic Fibrosis Foundation Patient Registry.美国囊性纤维化基金会患者注册中心的研究表明,囊性纤维化护理中的差距与肺功能下降有关。
Ann Am Thorac Soc. 2023 Sep;20(9):1250-1257. doi: 10.1513/AnnalsATS.202211-951OC.
6
[Italian Cystic Fibrosis Registry. Report 2011-2014].[意大利囊性纤维化注册中心。2011 - 2014年报告]
Epidemiol Prev. 2018 Jan-Feb;42(1S1):1-32. doi: 10.19191/EP18.1-S1.P001.001.
7
[Italian Cystic Fibrosis Register - Report 2010].[意大利囊性纤维化登记处——2010年报告]
Epidemiol Prev. 2016 Mar-Apr;40(2 Suppl 2):1-47. doi: 10.19191/EP16.2S2.P001.074.
8
Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.囊性纤维化患者呼吸道细菌学的流行病学变化
Chest. 2016 Feb;149(2):390-400. doi: 10.1378/chest.15-0676. Epub 2016 Jan 12.
9
Data that empower: The success and promise of CF patient registries.赋能数据:囊性纤维化患者登记处的成功与前景。
Pediatr Pulmonol. 2017 Nov;52(S48):S44-S51. doi: 10.1002/ppul.23790. Epub 2017 Sep 14.
10
Impact of loss to follow-up on survival estimation for cystic fibrosis.随访丢失对囊性纤维化患者生存估计的影响。
Ann Epidemiol. 2023 Oct;86:98-103.e5. doi: 10.1016/j.annepidem.2023.07.008. Epub 2023 Aug 6.

引用本文的文献

1
A dramatic decline in lung transplantation for cystic fibrosis in the United States.美国囊性纤维化患者肺移植数量急剧下降。
CHEST Pulm. 2024 Dec;2(4). doi: 10.1016/j.chpulm.2024.100077. Epub 2024 Jun 22.
2
Hypercubes to identify geomarkers of rapid cystic fibrosis lung disease progression.超立方体用于识别囊性纤维化肺病快速进展的地理标记物。
BMC Med Inform Decis Mak. 2025 Aug 13;25(1):304. doi: 10.1186/s12911-025-03097-2.
3
Validating the Data Completeness and Accuracy of the Canadian Cystic Fibrosis Registry.验证加拿大囊性纤维化登记处的数据完整性和准确性。
Can Respir J. 2025 Jul 1;2025:8893074. doi: 10.1155/carj/8893074. eCollection 2025.
4
Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the US.美国囊性纤维化肺移植受者使用依列卡福妥/替扎卡福妥/依伐卡托的处方情况。
J Cyst Fibros. 2025 Jul 1. doi: 10.1016/j.jcf.2025.06.005.
5
The Hydrocephalus Association Patient-Powered Interactive Engagement Registry (HAPPIER): Design and Initial Baseline Report.脑积水协会患者驱动的交互式参与登记处(HAPPIER):设计与初始基线报告。
Clin Epidemiol. 2025 Jun 24;17:567-579. doi: 10.2147/CLEP.S526203. eCollection 2025.
6
Tobacco smoke exposure is associated with diminished longitudinal benefit of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis.暴露于烟草烟雾与依列卡福/替扎卡福/艾伐卡福对囊性纤维化患者的长期疗效降低有关。
J Cyst Fibros. 2025 Jun 11. doi: 10.1016/j.jcf.2025.05.002.
7
Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID-19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model.新冠疫情期间的囊性纤维化学习网络远程医疗创新实验室:对医疗服务可及性、治疗结果及新型囊性纤维化护理模式的影响
Pediatr Pulmonol. 2025 May;60(5):e71102. doi: 10.1002/ppul.71102.
8
A Joint Model for (Un)Bounded Longitudinal Markers, Competing Risks, and Recurrent Events Using Patient Registry Data.一种使用患者登记数据的(无)界纵向标志物、竞争风险和复发事件的联合模型。
Stat Med. 2025 Apr;44(8-9):e70057. doi: 10.1002/sim.70057.
9
Exploring the utilisation and effectiveness of implementation science strategies by cystic fibrosis registries for healthcare improvement: a systematic review.探索囊性纤维化登记处利用实施科学策略改善医疗保健的情况及效果:一项系统评价。
Eur Respir Rev. 2025 Apr 16;34(176). doi: 10.1183/16000617.0227-2024. Print 2025 Apr.
10
Effects of azithromycin in young adults with cystic fibrosis: a protocol for emulating a published randomised controlled trial using registry data.阿奇霉素对年轻囊性纤维化患者的影响:一项使用登记数据模拟已发表随机对照试验的方案
BMJ Open. 2025 Mar 25;15(3):e091357. doi: 10.1136/bmjopen-2024-091357.